Testing effectiveness (Phase 2)Looking for participantsNCT06808984
What this trial is testing
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
Who this might be right for
AgitationAlzheimer Disease
Celgene 120